Primary Immune Deficiency Consortium Conference

这笔赠款用于研究员和教职员工的旅费以及与举办临床免疫学学会(CIS)有关的费用。 2006、2007和2008年的原发免疫缺陷联合会会议。美国国立卫生研究院支持的第一个 原发免疫缺陷联合会会议于2005年5月在波士顿举行，会议高度关注 成功。这项目前的赠款申请将提供资金，以支持与会者的旅行并协助 再做3年的项目开发。额外的资金将从制药公司和 生物技术公司。独联体初级免疫缺陷联合会会议的使命是 利用已有的指导计划，培训年轻的调查人员进行诊断和 在鼓励的环境下，在密集会议上治疗原发免疫缺陷疾病 互动参与。独联体，与USIDNet财团合作，由国家 卫生研究院将于2006年6月在旧金山举办另一项为期一天的强化课程， 加利福尼亚。随后的两次会议将在美国大陆另外两个主要城市举行，以配合 非常成功的Focis会议的第一天，以扩大广大观众的参与。的话题 这些会议将是初级免疫缺陷，并将包括面向更多高级研究员的会议 培训，初级教员，以及该领域的知名专家。首要目标是继续前进 关于这些复杂免疫的诊断、分子缺陷、并发症和治疗的教育 缺乏症。次要目标是在这一领域发展新科学家的职业生涯 学术医学；以及提高对临床免疫学的认识及其在科学上的重要性 发现和临床应用。第三组目标是促进未来两国之间的合作 不同医学中心和国家的年轻研究人员，以及新的研究人员和 该领域经验丰富的医生/科学家。这些会议将包括正式陈述、案例和 与新调查人员和经验丰富的教职员工进行小组讨论。每个会议的参与者将 包括二十(20)名教职员工和六十(60)名年轻研究人员。主要主题将集中在：诊断 免疫缺陷；遗传学、免疫重建、标准疗法和新疗法的使用。

This grant is for fellows' and faculty travel and expenses related to holding Clinical Immunology Society (CIS) Primary Immune Deficiency Consortium Conferences, 2006, 2007, and 2008. The first NIH supported Primary Immune Deficiency Consortium Conference was held May 2005 in Boston, and was highly successful. This current grant request will provide the funding to support travel for the participants and assist with program development for a further 3 years. Additional funding will be solicited from pharmaceutical and biotechnology companies. The mission of the CIS Primary Immune Deficiency Consortium Conferences are to capitalize upon a mentoring program already in place to train young investigators in the diagnosis and treatment of primary immunodeficiency diseases in intensive meetings in a setting that encourages interactive participation. The CIS, in collaboration with the USIDNet Consortium funded by the National Institutes of Health, will develop another intensive one day course to be held in June 2006 in San Francisco, California. Two subsequent meetings will be held in 2 other continental US major cities to coincide with the first day of the highly successful FOCIS meetings to amplify participation by a wide audience. The topic of these conferences will be Primary Immunodeficiency, and will include geared towards more senior fellows in training, junior faculty, as well as noted experts in the field. The primary goal is to continue to advance education on the diagnosis, molecular defects, complications, and treatment of these complex immune deficiency diseases. The secondary goals are to develop the careers of new scientists in this area of academic medicine; and to enhance awareness of Clinical Immunology and its importance in scientific discoveries and clinical applications. The third set of goals is to stimulate future collaborations between young investigators in different medical centers and countries, and between new investigators and experienced physician/scientists in the field. These conferences will include formal presentations, case and panel discussions with new investigators and experienced faculty. Participants at each conference will include twenty (20) faculty and sixty (60) young investigators. Principle topics will focus on: Diagnosis of Immunodeficiency; Genetics, Immune Reconstruction, and the Use of Standard and Novel Therapies.